Expert recommendations on treatment sequencing and challenging clinical scenarios in human epidermal growth factor receptor 2-positive (HER2-positive) metastatic breast cancer.
- DOI
- 10.1016/j.ctrv.2024.102853
- Published
- 2025 Jan
- Container
- Cancer treatment reviews
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.ctrv.2024.102853,
title = {Expert recommendations on treatment sequencing and challenging clinical scenarios in human epidermal growth factor receptor 2-positive (HER2-positive) metastatic breast cancer.},
author = {Bartsch R and Cameron D and Ciruelos E and Criscitiello C and Curigliano G and Duhoux FP and Foukakis T and Gligorov J and Harbeck N and LeVasseur N and Okines A and Penault-Llorca F and Müller V},
year = {2025},
journal = {Cancer treatment reviews},
doi = {10.1016/j.ctrv.2024.102853},
url = {https://doi.org/10.1016/j.ctrv.2024.102853}
}RIS
TY - JOUR TI - Expert recommendations on treatment sequencing and challenging clinical scenarios in human epidermal growth factor receptor 2-positive (HER2-positive) metastatic breast cancer. AU - Bartsch R AU - Cameron D AU - Ciruelos E AU - Criscitiello C AU - Curigliano G AU - Duhoux FP AU - Foukakis T AU - Gligorov J AU - Harbeck N AU - LeVasseur N AU - Okines A AU - Penault-Llorca F AU - Müller V PY - 2025 JO - Cancer treatment reviews DO - 10.1016/j.ctrv.2024.102853 UR - https://doi.org/10.1016/j.ctrv.2024.102853 ER -
APA
R, B., D, C., E, C., C, C., G, C., FP, D., T, F., J, G., N, H., N, L., A, O., F, P., & V, M. (2025). Expert recommendations on treatment sequencing and challenging clinical scenarios in human epidermal growth factor receptor 2-positive (HER2-positive) metastatic breast cancer.. Cancer treatment reviews. https://doi.org/10.1016/j.ctrv.2024.102853
Source records
- pubmed · retrieved 2026-09-25T15:40:48.210Z